ES2115231T3 - Emplasto con sustancias activas. - Google Patents

Emplasto con sustancias activas.

Info

Publication number
ES2115231T3
ES2115231T3 ES94913616T ES94913616T ES2115231T3 ES 2115231 T3 ES2115231 T3 ES 2115231T3 ES 94913616 T ES94913616 T ES 94913616T ES 94913616 T ES94913616 T ES 94913616T ES 2115231 T3 ES2115231 T3 ES 2115231T3
Authority
ES
Spain
Prior art keywords
plaster
active substances
polymer
vitamin
referred
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94913616T
Other languages
English (en)
Inventor
Wilfried Fischer
Karin Klokkers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hexal AG
Original Assignee
Hexal AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19934339400 external-priority patent/DE4339400A1/de
Application filed by Hexal AG filed Critical Hexal AG
Application granted granted Critical
Publication of ES2115231T3 publication Critical patent/ES2115231T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Laminated Bodies (AREA)

Abstract

LA INVENCION SE REFIERE A EMPLASTOS CONTENIENDO SUSTANCIA ACTIVA EN FORMA DE EMPLASTO LAMINADO, DONDE COMO EMPLASTO SE DISPONE DE UN SOPORTE Y UNA MATRIZ A BASE DE UN POLIMERO INDIVIDUAL Y EVENTUALMENTE UN OTRO POLIMERO ASI COMO VITAMINA E.
ES94913616T 1993-04-20 1994-04-20 Emplasto con sustancias activas. Expired - Lifetime ES2115231T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4312818 1993-04-20
DE19934339400 DE4339400A1 (de) 1993-11-18 1993-11-18 Wirkstoffpflaster

Publications (1)

Publication Number Publication Date
ES2115231T3 true ES2115231T3 (es) 1998-06-16

Family

ID=25925074

Family Applications (2)

Application Number Title Priority Date Filing Date
ES94913616T Expired - Lifetime ES2115231T3 (es) 1993-04-20 1994-04-20 Emplasto con sustancias activas.
ES97113342T Expired - Lifetime ES2164286T3 (es) 1993-04-20 1994-04-20 Emplasto con sustancias activas.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES97113342T Expired - Lifetime ES2164286T3 (es) 1993-04-20 1994-04-20 Emplasto con sustancias activas.

Country Status (14)

Country Link
US (2) US5683711A (es)
EP (2) EP0813865B1 (es)
JP (1) JP3489831B2 (es)
AT (2) ATE205706T1 (es)
AU (1) AU678237B2 (es)
CA (1) CA2161004C (es)
DE (2) DE59409873D1 (es)
DK (2) DK0813865T3 (es)
ES (2) ES2115231T3 (es)
FI (1) FI114782B (es)
HU (2) HU223042B1 (es)
NO (1) NO311829B1 (es)
PT (1) PT813865E (es)
WO (1) WO1994023707A1 (es)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4429667C2 (de) * 1994-08-20 1996-07-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
DE19517145C2 (de) * 1995-05-10 2000-02-24 Hexal Pharmaforschung Gmbh Transdermales therapeutisches System (TTS) zur Verabreichung von Testosteron
US6316022B1 (en) * 1995-06-07 2001-11-13 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
CA2223588C (en) 1995-06-07 2004-01-06 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
DE19533089C1 (de) 1995-09-07 1997-05-22 Hexal Ag Tacrin-Pflaster
DE19642043A1 (de) * 1995-10-23 1997-04-24 Hexal Ag Transdermales therapeutisches System (TTS) für die Verabreichung von Wirkstoffen zur Behandlung von Drogenabhängigkeit oder Drogensucht
DE19548332A1 (de) * 1995-12-22 1997-07-10 Rotta Res Bv Hormonpflaster
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US20020012694A1 (en) * 1997-09-17 2002-01-31 Alfred J. Moo-Young Transdermal administration of ment
US6767902B2 (en) 1997-09-17 2004-07-27 The Population Council, Inc. Androgen as a male contraceptive and non-contraceptive androgen replacement
AU1800099A (en) 1997-11-25 1999-06-15 Theratech, Inc. Transdermal delivery devices containing polydiorganosiloxane polymers to regulate adhesive properties
DE19814257A1 (de) 1998-03-31 1999-10-07 Asta Medica Ag Brauseformulierungen
DE19828273B4 (de) * 1998-06-25 2005-02-24 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
US6475514B1 (en) 1998-12-03 2002-11-05 Andrew Blitzer Athletic patch
DE19859910C2 (de) * 1998-12-23 2001-03-22 Ratiopharm Gmbh Orales Arzneimittel
DK1154759T3 (da) 1998-12-30 2008-12-08 Dexcel Ltd Dispergerbart koncentrat til indgift af cyclosporin
US6417227B1 (en) 1999-04-28 2002-07-09 Cg And Associates Methods of delivery of cetyl myristoleate
US6358939B1 (en) 1999-12-21 2002-03-19 Northern Lights Pharmaceuticals, Llc Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
US6989377B2 (en) 1999-12-21 2006-01-24 Wisconsin Alumni Research Foundation Treating vitamin D responsive diseases
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US7235397B1 (en) 2000-04-14 2007-06-26 Gensys, Inc. Methods and compositions for culturing spirochete and treating spirochetal diseases
DE10043321B4 (de) * 2000-08-24 2005-07-28 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
US20020119187A1 (en) * 2000-09-29 2002-08-29 Cantor Adam S. Composition for the transdermal delivery of fentanyl
US20020198215A1 (en) * 2000-10-23 2002-12-26 Lino Tavares Terazosin transdermal device and methods
DE10141651B4 (de) * 2001-08-24 2007-02-15 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
DE10141652B4 (de) * 2001-08-24 2011-04-07 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung
US20040258739A1 (en) * 2001-09-04 2004-12-23 Rudy Susilo Plaster for the treatment of dysfunctions and disorders of nails
DE60312160T2 (de) * 2002-06-10 2007-10-31 Euro-Celtique S.A. Entsorgungssysteme für transdermale abgabevorrichtungen zur verhinderung des missbrauchs von darin enthaltenen wirkstoffen
NZ541576A (en) * 2003-02-07 2008-03-28 Lohmann Therapie Syst Lts Transdermal therapeutic system suitable for heat application for promoting the permeation of active substances, and the use thereof
CZ295826B6 (cs) * 2003-04-28 2005-11-16 Ústav Makromolekulární Chemie Av Čr Materiál pro krytí ran obsahující lapače radikálů
UA84303C2 (ru) * 2003-10-28 2008-10-10 Новен Фармасьютикалз, Инк. Система для трансдермальной доставки лечебного средства
US20050096311A1 (en) * 2003-10-30 2005-05-05 Cns Response Compositions and methods for treatment of nervous system disorders
DE102004059880A1 (de) * 2004-12-10 2006-06-14 Grünenthal GmbH Stabiles, hormonhaltiges (Zwischen-)Produkt
WO2006082728A1 (ja) * 2005-02-04 2006-08-10 Hisamitsu Pharmaceutical Co., Inc. 経皮吸収貼付剤
US20070018059A1 (en) * 2005-07-25 2007-01-25 Woodcock John E Apparatus for holding a container at an angle
AU2008204710C1 (en) * 2007-01-11 2013-07-18 Drossapharm Ag Medically active plaster
US8513323B2 (en) * 2007-06-22 2013-08-20 Kimbery-Clark Worldwide, Inc. Multifunctional silicone blends
ES2528650T3 (es) 2010-11-17 2015-02-11 Hexal Ag Sistema terapéutico transdérmico que comprende buprenorfina
JP6893086B2 (ja) 2013-03-13 2021-06-23 エーブリー デニソン コーポレイション 接着特性の向上

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7711916A (nl) * 1977-10-29 1979-05-02 Akzo Nv Werkwijze ter bereiding van sterk geconcen- treerde farmaceutische preparaten van steroiden.
US4439432A (en) * 1982-03-22 1984-03-27 Peat Raymond F Treatment of progesterone deficiency and related conditions with a stable composition of progesterone and tocopherols
JPS59184121A (ja) * 1983-03-31 1984-10-19 Nitto Electric Ind Co Ltd アクリル系膏体
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
CH674618A5 (es) * 1987-04-02 1990-06-29 Ciba Geigy Ag
US5300291A (en) * 1988-03-04 1994-04-05 Noven Pharmaceuticals, Inc. Method and device for the release of drugs to the skin
GB8807504D0 (en) * 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds
JP2857882B2 (ja) * 1988-11-02 1999-02-17 富山化学工業株式会社 ピロキシカムのプラスター剤
DE3902013A1 (de) * 1989-01-25 1990-09-20 Knoll Ag Pflaster zur transdermalen anwendung
JP2875611B2 (ja) * 1990-08-29 1999-03-31 エーザイ株式会社 ケイ酸カルシウム含有外用剤
GB9021674D0 (en) * 1990-10-05 1990-11-21 Ethical Pharma Ltd Transdermal device
DE4116912A1 (de) * 1991-05-18 1992-11-26 Schering Ag Mittel zur transdermalen applikation enthaltend ergolin-derivate
NZ244862A (en) * 1991-10-23 1995-07-26 Block Drug Co Use of vitamin e in topical pharmaceuticals to enhance penetration of the active agent
DE4237453C1 (es) * 1992-11-06 1993-08-19 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De

Also Published As

Publication number Publication date
CA2161004A1 (en) 1994-10-27
FI954989L (fi) 1995-10-19
ATE205706T1 (de) 2001-10-15
FI114782B (fi) 2004-12-31
AU678237B2 (en) 1997-05-22
ES2164286T3 (es) 2002-02-16
EP0813865B1 (de) 2001-09-19
AU6569694A (en) 1994-11-08
DK0695177T3 (da) 1998-09-28
HUT73668A (en) 1996-09-30
NO311829B1 (no) 2002-02-04
CA2161004C (en) 2004-10-26
ATE163262T1 (de) 1998-03-15
HU0301253D0 (en) 2003-07-28
US5830505A (en) 1998-11-03
NO954186L (no) 1995-10-19
FI954989A0 (fi) 1995-10-19
HU223042B1 (hu) 2004-03-01
HU223045B1 (hu) 2004-03-01
JP3489831B2 (ja) 2004-01-26
DE59405277D1 (de) 1998-03-26
PT813865E (pt) 2002-02-28
EP0813865A1 (de) 1997-12-29
NO954186D0 (no) 1995-10-19
US5683711A (en) 1997-11-04
EP0695177B1 (de) 1998-02-18
WO1994023707A1 (de) 1994-10-27
JPH09501398A (ja) 1997-02-10
EP0695177A1 (de) 1996-02-07
HU9502994D0 (en) 1995-12-28
DE59409873D1 (de) 2001-10-25
DK0813865T3 (da) 2001-11-19

Similar Documents

Publication Publication Date Title
ES2164286T3 (es) Emplasto con sustancias activas.
ES2130420T3 (es) Preparado transdermico de sustancia activa.
DE50015813D1 (de) Elektrochemische herstellung von peroxo-dischwefelsäure unter einsatz von diamantbeschichteten elektroden
ES2195220T3 (es) Acidos sulfonilaminocarboxilicos.
EE03105B1 (et) Farmakoloogilist ioniseeruvat toimeainet sisaldavad ravimvormid ja nende valmistamise protsess
ES2045229T3 (es) Pirrolidinas 1,3-disubstituidas.
ATE342097T1 (de) Elektroaktive pore
ES2138271T3 (es) Compuestos de 6-dimetil-amino-metil-1-fenil-ciclohexano como principio activo farmaceutico.
DE68910867D1 (de) Matrix für die transdermale Abgabe von Arzneimitteln.
ES2165640T3 (es) Acidos diaminocarboxilicos sustituidos.
ES2143641T3 (es) Expresion en superficie de una enzima en la terapia genica a base de promedicamentos.
ES2059299T1 (es) Metodo para el direccionado de un agente terapeutico a una poblacion especifica de celulas.
DK324687A (da) Transdermalt farmeceutisk praeparat
ES2176961T3 (es) Mezclas solidas a base de sulfonilureas y adyuvantes.
ES2056981T3 (es) Composiciones dotadas de una capacidad de penetracion mejorada.
ATE311858T1 (de) Dosierungsform mit flüssiger formulierung
ES2080037T3 (es) Medicamento de uso topico con actividad cicatrizante.
ES2156220T3 (es) Preparacion transdermica que contiene un metabolito de loratidina con accion antihistaminica.
ES2055291T3 (es) Material de gel acrilico y preparacion de gel acrilico.
ES2061787T3 (es) Combinacion de inhibidores de la enzima de conversion de la angiotensina con moduladores del canal del potasio, asi como su empleo en medicamentos.
BR9802803A (pt) ação e composições farmacêuticas contendo os mesmos.
ES2152315T3 (es) Xamoneline tartrato.
DE59607949D1 (de) Feste arzneimittelform mit polymerem material verteiltem wirkstoff
TR199800008T1 (xx) Ametokain ihtiva eden suyla aktive edilebilir yap��kan matrisi.
TR22867A (tr) Birden fazla aktif bilesen ihtiva eden insektisid terkibi

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 695177

Country of ref document: ES